Ownership Summary
Baird Medical Investment Holdings Ltd (NASDAQ:BDMD) showed up in the 13F filings of 8 institutional investors as of December 2025.
- These investors collectively held 2.0% of Baird Medical Investment Holdings's outstanding shares in December 2025, up from 1.7% in September 2025.
- Their total shares held in BDMD increased 36.43% from the prior quarter, while the number of investors in Baird Medical Investment Holdings increased 14.29% year over year.
- Among the 8 funds, 3 bought more Baird Medical Investment Holdings shares, 1 sold down, and 4 held their ground.
- Combined, these investors held 529.36K shares in BDMD for December 2025, up by 141.36K shares quarter on quarter, and up 223.86K shares year over year.
- Jpmorgan Chase & Co holds the largest position in BDMD at 125.0K shares as of December 31, 2025, or 0.47% of shares outstanding.
- The most significant purchases of BDMD for the quarter ending December 2025 came from Jpmorgan Chase & Co (125.0K), JANE STREET GROUP, LLC (39.42K), UBS Group AG (33.96K), Morgan Stanley (20.0K).
- The biggest sellers of Baird Medical Investment Holdings for the quarter ending December 2025 included TWO SIGMA INVESTMENTS, LP (48.86K).
- Business Quant data shows the 9 biggest positions in Baird Medical Investment Holdings as of December 2025 are held by Jpmorgan Chase & Co (125.0K), HIGHBRIDGE CAPITAL MANAGEMENT LLC (125.0K), UBS Group AG (67.86K), TWO SIGMA INVESTMENTS, LP (46.59K), JANE STREET GROUP, LLC (39.42K), GEODE CAPITAL MANAGEMENT, LLC (25.44K), Morgan Stanley (20.0K), NATIONAL BANK OF CANADA /FI/ (11.7K), WOLVERINE ASSET MANAGEMENT LLC (205).